Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
triamcinolonacetonid præparat til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
triamcinolonacetonid 40 mg/ml injektionsvæske, suspension i fyldt injektionssprøjte a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
triamcinolonacetonid 40 mg/ml injektionsvæske, suspension i fyldt injektionssprøjte a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
Triamcinolone acetonide [musculoskeletal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
triamcinolonacetonid 10 mg/ml injektionsvæske, suspension, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
triamcinolonacetonid 10 mg/ml injektionsvæske, suspension, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
triamcinolonacetonid 40 mg/1 ml injektionsvæske til intraartikulær/intramuskulær anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
triamcinolonacetonid 55 µg vandig næsespray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
Triamcinolone acetonide 1 mg/g oromucosal paste |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
Triamcinolone acetonide [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
Triamcinolone acetonide 1 mg/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
triamcinolonacetonid 0,05 % |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
triamcinolonacetonid 50 µg spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
triamcinolonacetonid 40 mg injektionsvæske, suspension, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
Triamcinolone acetonide 250 microgram/mL cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
Product containing precisely triamcinolone acetonide 5 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
triamcinolonacetonid 0,055 mg/inhalation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
triamcinolonacetonid 3 mg injektionsvæske, suspension, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
triamcinolonacetonid 200 µg spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
triamcinolonacetonid 40 mg/ml suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
Triamcinolone acetonide 55mcg/spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
triamcinolonacetonid 100 µg spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
Triamcinolone acetonide 55mcg spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
Triamcinolone acetonide 1 mg/mL cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
nystatin 100.000 enheder + triamcinolonacetonid 1 mg creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
nystatin 100.000 enheder + triamcinolonacetonid 1 mg salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
nystatin 10.000 enheder + triamcinolonacetonid 1 mg salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
triamcinolonacetonid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
Product containing precisely triamcinolone acetonide 50 microgram/1 actuation conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
triamcinolonacetonid 0,055 mg/inhalation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
triamcinolonacetonid 40 mg/ml injektionsvæske, suspension, hætteglas a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
triamcinolonacetonid 40 mg/ml injektionsvæske, suspension, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
triamcinolonacetonid 40 mg/ml injektionsvæske, suspension, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
Triamcinolone acetonide 1 mg/mL cutaneous lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
Triamcinolone acetonide 80mg/mL injection suspension 0.1mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
triamcinolonacetonid 0,1 % + chlortetracyclinhydrochlorid 3 % salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
|
Triamcinolone acetonide 1 mg/g oromucosal paste |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Triamcinolone acetonide 1 mg/g oromucosal paste |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely neomycin 3.5 milligram/1 milliliter and triamcinolone acetonide 1 milligram/1 milliliter conventional release ear drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely neomycin 3.5 milligram/1 milliliter and triamcinolone acetonide 1 milligram/1 milliliter conventional release ear drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely triamcinolone acetonide 50 milligram/5 milliliter conventional release suspension for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely triamcinolone acetonide 50 milligram/5 milliliter conventional release suspension for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely triamcinolone acetonide 40 milligram/1 milliliter conventional release suspension for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely triamcinolone acetonide 40 milligram/1 milliliter conventional release suspension for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Triamcinolone acetonide 55 microgram/actuation nasal spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Triamcinolone acetonide 55 microgram/actuation nasal spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely triamcinolone acetonide 10 milligram/1 milliliter conventional release suspension for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely triamcinolone acetonide 10 milligram/1 milliliter conventional release suspension for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely triamcinolone acetonide 40 milligram/1 milliliter conventional release suspension for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely triamcinolone acetonide 40 milligram/1 milliliter conventional release suspension for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely triamcinolone acetonide 80 milligram/2 milliliter conventional release suspension for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely triamcinolone acetonide 80 milligram/2 milliliter conventional release suspension for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely triamcinolone acetonide 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely triamcinolone acetonide 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Triamcinolone acetonide 10 mg/mL suspension for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Triamcinolone acetonide 10 mg/mL suspension for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Triamcinolone acetonide 250 microgram/mL cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Triamcinolone acetonide 250 microgram/mL cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely triamcinolone acetonide 5 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely triamcinolone acetonide 5 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Triamcinolone acetonide 1 mg/mL cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Triamcinolone acetonide 1 mg/mL cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Triamcinolone acetonide 1 mg/g cutaneous ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Triamcinolone acetonide 1 mg/g cutaneous ointment |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Triamcinolone acetonide 1 mg/mL cutaneous lotion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Triamcinolone acetonide 1 mg/mL cutaneous lotion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely triamcinolone acetonide 50 microgram/1 actuation conventional release nasal spray (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely triamcinolone acetonide 50 microgram/1 actuation conventional release nasal spray (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Triamcinolone acetonide 3 mg/mL suspension for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Triamcinolone acetonide 3 mg/mL suspension for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely neomycin 3.5 milligram/1 milliliter and triamcinolone acetonide 1 milligram/1 milliliter conventional release ear drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely neomycin 3.5 milligram/1 milliliter and triamcinolone acetonide 1 milligram/1 milliliter conventional release ear drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely econazole nitrate 10 milligram/1 gram and triamcinolone acetonide 1 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely econazole nitrate 10 milligram/1 gram and triamcinolone acetonide 1 milligram/1 gram conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Triamcinolone acetonide (substance) |
Inferred relationship |
Some |
1 |